Keyphrases
Parkinson's Disease
100%
Leucine-rich Repeat Kinase 2 (LRRK2)
46%
Parkinson Patients
20%
Patients with Parkinson's Disease
20%
Non-manifesting Carriers
18%
Essential Tremor
16%
Israel
16%
Movement Disorders
15%
G2019S mutation
12%
Columbia University
11%
Non-associated
10%
Huntington's Disease
10%
University Medical Centre
10%
Deep Brain Stimulation Surgery
10%
Hebrew Version
10%
Disease Severity
10%
Advanced Parkinson's Disease
9%
Idiopathic Parkinson's Disease
8%
Mutation Carriers
8%
Tremor
8%
LRRK2 Gene
8%
Clinical Characteristics
7%
Tremor Disease
7%
Movement Disorder Society
7%
Healthy Controls
7%
Unified Parkinson's Disease Rating Scale (UPDRS)
6%
Patient Characteristics
6%
Non-carriers
6%
Disease-related
6%
G2019S
6%
Parkinsonism
6%
Prodromal Parkinson's Disease
5%
IPX066
5%
Nocturnal Movements
5%
Differential Screening
5%
Mountain Jews
5%
Ethnic Cluster
5%
Karaites
5%
Parkinson's Disease Risk
5%
Fall Risk
5%
Neuroblastoma
5%
18F-DOPA PET
5%
Unified Dyskinesia Rating Scale
5%
Metabolic Syndrome
5%
Neurogenesis
5%
MS Patients
5%
Clinical Features
5%
Interferon-α (IFN-α)
5%
Gait
5%
Biochemical Markers
5%
Medicine and Dentistry
Parkinson's Disease
39%
Stereotypic Movement Disorder
14%
Rating Scale
10%
Essential Tremor
10%
Deep Brain Stimulation
10%
Huntington's Disease
10%
Fluorine-18
5%
Metabolic Syndrome
5%
Methotrexate
5%
Polyethylene Terephthalate
5%
Observational Study
5%
Clinician
5%
Amantadine
5%
Parkinsonism
5%
Diagnosis of Parkinson's Disease
5%
Dyskinesia
5%
Fiber Optics
5%
Plummer-Vinson Syndrome
5%
Heart Innervation
5%
Infusion
5%
Multiple Sclerosis
5%
Health Service
5%
Neurology
5%
